Total planned funding: $122,732,040
Allocations
Countries/Regions
Ukraine | $122,732,040 |
Organizational Types
Private Contractor | $32,764,481 |
Unknown | $25,143,032 |
NGO | $22,894,854 |
Multi-lateral Agency | $15,151,607 |
Own Agency | $13,393,972 |
University | $5,460,000 |
Other USG Agency | $5,224,094 |
Implementing Agency | $2,700,000 |
Program Areas
Governance and Systems | $52,562,579 |
Treatment | $24,505,798 |
Prevention | $13,971,614 |
Testing | $12,453,102 |
Care | $10,281,056 |
Management and Operations | $8,545,191 |
Budget Codes
OHSS: Health Systems Strengthening | $25,382,410 |
HVSI: Strategic Information | $16,690,940 |
HTXS: Treatment: Adult Treatment | $13,100,508 |
HVCT: Testing: HIV Testing and Counseling | $12,453,102 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $10,489,229 |
HVMS: Management and Operations | $8,545,191 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,085,928 |
HVTB: Care: TB/HIV | $6,067,290 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,949,107 |
HMBL: Biomedical Prevention: Blood Safety | $2,460,722 |
HBHC: Care: Adult Care and Support | $2,145,590 |
HKID: Care: Orphans and Vulnerable Children | $2,068,176 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $182,500 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$25,847,748
Countries/Regions
Chemonics International:
$17,739,470
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions
USG Aggregated Agencies:
$12,044,972
Countries/Regions